Trends in Diabetes Complication

With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing Type 2 diabetic population and introduction of technologically advanced therapies for battling complications associated to Type 2 Diabetes like the most prevalent Diabetes Cardiomyopathy. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease like diabetes.

  • Microvascular complications: Retinopathy, neuropathy, and nephropathy
  • Macrovascular complications: Coronary artery diseases, cardiomyopathy, and stroke
  • Latent autoimmune diabetes of adults (LADA)
  • Hypoglycemia - treatment and complications
  • Gender differences in hypoglycemia responses or metabolism
  • Diabetic gastroparesis
  • Type 1 diabetes -Complications and treatment
  • Type 2 diabetes -Complications and treatment
  • Immune intervention in type 1 diabetes
  • Gestational diabetes and treatment
  • Paediatric diabetes and treatment
  • Hypertension
  • Diabetic Mastopathy
  • Diabetic Myelopathy
  • Euglycemia gestational diabetes

Related Conference of Trends in Diabetes Complication

Trends in Diabetes Complication Conference Speakers